GlaxoSmithKline Retained Earnings:
1.970B for March 31, 2013GlaxoSmithKline Historical Retained Earnings Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.970B |
| Dec. 31, 2012 | 1.051B |
| Sept. 30, 2012 | 1.732B |
| June 30, 2012 | 3.183B |
| March 31, 2012 | 6.313B |
| Dec. 31, 2011 | 5.195B |
| Sept. 30, 2011 | 4.902B |
| June 30, 2011 | 7.203B |
| March 31, 2011 | 7.981B |
| Dec. 31, 2010 | 7.408B |
| Sept. 30, 2010 | 9.227B |
| June 30, 2010 | 7.397B |
| March 31, 2010 | 10.28B |
| Dec. 31, 2009 | 10.16B |
| Sept. 30, 2009 | 9.105B |
| June 30, 2009 | 7.054B |
| March 31, 2009 | 6.581B |
| Dec. 31, 2008 | 6.687B |
| Sept. 30, 2008 | 7.383B |
| June 30, 2008 | 8.503B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Retained Earnings
The net income that remains after paying dividends. It is reported on the balance sheet as the cumulative sum of each year's retained earnings over the life of the business. Retained earnings can be used to pay debt and future dividends, or can be reinvested into business activities.
The "retained" refers to the earnings after paying out dividends. Companies with increasing retained earnings is good, because it means the company is staying consistently profitable. If a company has a yearly loss, this number is subtracted from retained earnings.
If a company's annual net income was 5 million, paid out 3 million in dividends, and had a retained earnings of 9 million, retained earnings at the end of 2012 would be 11 million (5-3+9). Similarly if next year the company paid no dividends but had a yearly net income loss of 5 million, retained earnings would be 6 million (11-5).
Learn More
GSK Retained Earnings Benchmarks
| Companies | |
|---|---|
| Pfizer | |
| Sanofi | |
| AstraZeneca | 16.37B |
GSK Retained Earnings Rankings
| Overall |
93rd percentile 521 of 7593 |
| Sector |
93rd percentile 40 of 650 in Healthcare |
| Industry |
90th percentile 5 of 52 in Drug Manufacturers - Major |
GSK Retained Earnings Range, Past 5 Years
| Minimum | 1.051B | Dec 2012 |
| Maximum | 10.28B | Mar 2010 |
| Average | 6.466B |
